S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
The Top 3 Stocks to Buy in March 2021
3 Undervalued Mid-caps with Good Upside
Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some
House passes $1.9T pandemic bill on near party-line vote
MarketBeat: Week in Review 2/22 – 2/26
Closing prices for crude oil, gold and other commodities
House passes $1.9T pandemic relief bill, sends it to Senate
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
The Top 3 Stocks to Buy in March 2021
3 Undervalued Mid-caps with Good Upside
Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some
House passes $1.9T pandemic bill on near party-line vote
MarketBeat: Week in Review 2/22 – 2/26
Closing prices for crude oil, gold and other commodities
House passes $1.9T pandemic relief bill, sends it to Senate
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
The Top 3 Stocks to Buy in March 2021
3 Undervalued Mid-caps with Good Upside
Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some
House passes $1.9T pandemic bill on near party-line vote
MarketBeat: Week in Review 2/22 – 2/26
Closing prices for crude oil, gold and other commodities
House passes $1.9T pandemic relief bill, sends it to Senate
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
The Top 3 Stocks to Buy in March 2021
3 Undervalued Mid-caps with Good Upside
Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some
House passes $1.9T pandemic bill on near party-line vote
MarketBeat: Week in Review 2/22 – 2/26
Closing prices for crude oil, gold and other commodities
House passes $1.9T pandemic relief bill, sends it to Senate
Log in
CVE:IFOS

Itafos (IFOS.V) Social Media Mentions

C$0.72
+0.05 (+7.46 %)
(As of 02/26/2021 03:48 PM ET)
Add
Compare
Today's Range
C$0.57
Now: C$0.72▼
C$0.72
50-Day Range
C$0.00
MA: C$0.58▼
C$0.80
52-Week Range
C$0.21
Now: C$0.72▼
C$0.83
Volume16,500 shs
Average Volume21,007 shs
Market CapitalizationC$133.53 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Social Media

This page was last updated on 2/27/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.